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c-Jun and JunB Antagonistically Control
Cytokine-Regulated Mesenchymal–Epidermal
Interaction in Skin
apoptosis in response to genotoxic agents (Kolbus et
al., 2000) and cell proliferation (Johnson et al., 1993;
Schreiber et al., 1999). In addition to this cell-autono-
mous regulatory function in cell proliferation, Jun pro-
teins may also affect cell proliferation and differentiation
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via a transregulatory mechanism by modulating the ex-Control
pression of factors, such as Il-2 and Il-4 (Muegge et al.,†Division of Carcinogenesis and Differentiation
1989; Li et al., 1999), which act on neighboring cellsDeutsches Krebsforschungszentrum
in a paracrine fashion. However, Jun-regulated geneticIm Neuenheimer Feld 280
programs, which modulate proliferation and differentia-69120 Heidelberg
tion of adjacent cells, have not yet been identified.Germany
A suitable in vivo system to study transregulatory
functions of Jun proteins is the skin. The formation and
maintenance of the mature epidermis rely on a tightlySummary
balanced process of keratinocyte proliferation and ter-
minal differentiation. This is regulated by interactionsInteractions between mesenchymal and epithelial
with the adjacent connective tissue (Fusenig, 1994;cells are responsible for organogenesis and tissue ho-
Schro¨der, 1995) via a cytokine network between kera-meostasis. This mutual cross-talk involves cell surface
tinocytes and dermal fibroblasts (Guo et al., 1993; Fu-proteins and soluble factors, which are mostly the re-
senig, 1994; Werner et al., 1994) both during skin devel-sult of regulated transcription. To elucidate dimer-
opment and skin regeneration (Werner et al., 1992; Finchspecific functions of the AP-1 family of transcription
et al., 1995a). The jun genes are expressed in cells of thefactors, we reconstituted skin by combining primary
dermis and epidermis (Welter and Eckert, 1995; M. S.-K.human keratinocytes and mouse wild-type, c-jun2/2,
and P. A., unpublished data), and transgenic mice haveand junB2/2 fibroblasts. We have discovered an antag-
suggested a critical role of AP-1 target genes in skinonistic function of these AP-1 subunits in the fibro-
tumorigenesis (Schuh et al., 1990; Bossy-Wetzel et al.,blast-mediated paracrine control of keratinocyte pro-
1992; Saez et al., 1995; Young et al., 1999).liferation and differentiation, and traced this effect to
The embryonic lethal phenotype of the c-jun2/2 andthe IL-1-dependent regulation of KGF and GM-CSF.
junB2/2 embryos is complex and does not automaticallyThese data suggest that the relative activation state
reveal which molecular process is defective and whether
of these AP-1 subunits in a non-cell-autonomous,
the deficiency is cell autonomous. Importantly, at pres-
transregulatory fashion directs regeneration of the ent, no fibroblast-specific promoter has been described
epidermis and maintenance of tissue homeostasis in that would be required to specifically inactivate genes
skin. in dermal fibroblasts by conditional gene targeting.
Therefore, in vivo animal models are not yet available
to define the contribution of Jun-regulated genes in the
Introduction mesenchymal compartment for epidermal regeneration
and maintaining skin homeostasis. However, in vitro tis-
Transcription factor AP-1 mediates gene regulation in sue engineered skin equivalent models have been es-
response to many extracellular stimuli (Angel and Karin, tablished in which keratinocyte proliferation and differ-
1991; Whitmarsh and Davis, 1996; Karin et al., 1997). entiation is maintained under the control of cocultured
AP-1 represents a heterogeneous family consisting of fibroblasts to form a three-dimensionally organized epi-
members of the Jun, Fos, and ATF families. Evidence thelium (Bell et al., 1981; Fusenig, 1992). In these organo-
for specific functions of AP-1 subunits was shown for typic cocultures, human epidermal keratinocytes grow
air exposed on a matrix of collagen type I containingc-Jun and JunB, which act antagonistically to control
homologous human primary dermal fibroblasts (Fu-cell transformation, differentiation, and expression of
senig, 1992) or heterologous mouse cell lines (Kaur andAP-1-dependent target genes (Chiu et al., 1989; Schu¨tte
Carter, 1992; Choi and Fuchs, 1994). Under these con-et al., 1989; Deng and Karin, 1993; Bakiri et al., 2000).
ditions, keratinocytes form a typical epidermal tissueLoss of function approaches in mice led to the identifica-
architecture expressing characteristic differentiationtion of specific, nonoverlapping functions of c-Jun and
markers (Smola et al., 1998; Stark et al., 1999). In theseJunB in hepatogenesis and heart development (Hilberg
skin equivalents, additional aspects of epidermal biol-et al., 1993; Eferl et al., 1999) and placentation (Schorpp-
ogy became accessible, such as the re-epithelializationKistner et al., 1999), respectively. Fibroblasts derived
process during wound closure and the development offrom c-jun2/2 mouse fetuses exhibit severe defects in
the stratum corneum barrier (Ponec et al., 1997; Riki-
maru et al., 1997).‡ To whom correspondence should be addressed (e-mail:
To assess the role of c-Jun- and JunB-regulatedp.angel@dkfz-heidelberg.de).
genes in fibroblasts required for skin tissue homeosta-§ Present address: Research Institute of Molecular Pathology, Dr.
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derived from wild-type, c-jun2/2, and junB2/2 mouse em- which regulate proliferation and differentiation of kera-
tinocytes.bryos. Loss of either c-Jun or JunB had a dramatic
antagonistic impact on keratinocyte proliferation and
differentiation. Concomitantly, KGF and GM-CSF ex- Jun-Dependent Alterations in Fibroblast–
pression was affected. Thus, KGF and GM-CSF repre- Keratinocyte Cross-Talk Can Be Reverted
sent the first AP-1 targets, which are antagonistically by Exogenously Expressed c-Jun and JunB
regulated by these two AP-1 subunits. Moreover, a novel To prove that the observed phenotypes are solely due
function of GM-CSF in nonhematopoietic cell differenti- to the loss of c-Jun or JunB, we attempted to restore
ation could be identified. Our data imply that coordi- normal development of an epithelium by reintroduction
nated expression of KGF and GM-CSF as well as other of c-Jun and JunB expression vectors. c-Jun- and JunB-
yet to be identified cytokines in fibroblasts is controlled deficient fibroblasts were stably transfected with ex-
by the relative abundance of c-Jun and JunB to regulate pression vectors encoding c-Jun-ER or JunB-ER fusion
the regeneration and maintenance of the epidermal proteins, which consist of the full-length c-Jun or JunB
tissue. protein fused to the ligand binding domain of the estro-
gen receptor, and which can be activated posttransla-
tionally upon addition of the synthetic ligand 4-OH ta-Results
moxifen (Figure 2A and data not shown; S. A., P. A., and
M. S.-K., unpublished data). In the absence of 4-OHLack of c-Jun and JunB in Fibroblasts Affects
tamoxifen, coculture of keratinocytes with c-jun2/2/c-Jun-Proliferation and Differentiation of Primary
ER fibroblasts resulted in the formation of thin epitheliaKeratinocytes in Organotypic Cocultures
characterized by reduced proliferation and differentia-When immortalized fibroblasts derived from wild-type
tion (Figures 2B and 2C). Importantly, induction of themouse embryos (Schreiber et al., 1999) were used in
c-Jun-ER protein by hormone treatment allowed the ke-organotypic cocultures of collagen embedded fibro-
ratinocytes to restore a normal proliferation rate and toblasts and primary human keratinocytes, growth and
form epithelia, which consisted of multiple layers ex-differentiation of keratinocytes led to the formation of
pressing the differentiation markers K1/10 and loricrinepithelia after seven days. The epithelia from human-
(Figures 2B and 2C). Very similarly, hormone-dependentmouse cocultures were very similar to the originally de-
activation of JunB-ER in junB2/2 cells completely re-scribed cocultures containing human skin fibroblasts,
versed hyperproliferation of keratinocytes (Figure 2B)and developed essentially the same morphological fea-
and allowed the formation of wild-type-like epitheliatures and differentiation profiles as human skin (Figure
(Figure 2C). In cocultures containing wild-type and the1A). When we used c-Jun- or JunB-deficient fibroblasts,
parental mutant fibroblasts, 4-OH Tamoxifen alone haddramatic changes of epithelial structure were observed.
no significant effect on the corresponding phenotypesEpithelia of cocultures containing c-jun2/2 fibroblasts
(Figure 2B and data not shown). These data confirm thatconsisted of a much smaller number of cell layers (Figure
the specific alterations in epithelium development are1A), and the number of proliferating cells in the stratum
solely caused by the loss of c-Jun and JunB in thebasale was markedly reduced (Figure 1B). Keratohyalin
collagen-embedded fibroblasts.granules, which are characteristic markers of epidermal
differentiation and hallmarks of the stratum granulosum,
were missing. This was confirmed by the lack of filaggrin Lack of c-Jun and JunB Has Antagonistic
Effects on the Expression of KGFexpression (data not shown), and the strongly reduced
expression of the late differentiation marker loricrin (Fig- and GM-CSF in Fibroblasts
Next, we wanted to know the nature of fibroblast-derivedure 1A). An opposite phenotype was observed in epithe-
lia formed in cocultures with junB2/2 fibroblasts. Here, soluble factors transregulating keratinocyte growth and
differentiation. Previously, we found that keratinocyteskeratinocyte hyperproliferation was observed (Figure
1B) resulting in epithelia with an increased number of cell secrete IL-1 to induce expression of KGF and other
cytokines in fibroblasts that act back on keratinocyteslayers, which were arranged in a less stringent pattern
(Figure 1A). The zone of keratin 1/10 (K1/10) negative (Smola et al., 1993; Maas-Szabowski et al., 1999, 2000).
Therefore, we measured mRNA and protein levels ofcells was enlarged, as was the stratum granulosum,
which contained more keratohyalin granules. Moreover, several cytokines including TNF-a, KGF, and GM-CSF
in wild-type and mutant fibroblasts in the absence orthe localization of loricrin was scattered over a thicker
upper cell compartment. Very similar alterations in kera- presence of human keratinocytes and IL-1, respectively.
RT-PCR using mouse specific primers revealed an induc-tinocyte proliferation were observed in conventional
two-dimensional feeder-layer cocultures that contained tion in the expression of KGF and GM-CSF in wild-type
fibroblasts in the presence of keratinocytes (3.7- andgrowth arrested c-jun2/2 and junB2/2 fibroblasts, respec-
tively (data not shown). 33-fold, respectively; Figure 3A). Both KGF and GM-CSF
transcripts were hardly detectable in c-jun2/2 fibroblasts,No differences in the plating efficiency of keratino-
cytes were observed whether wild-type or mutant fibro- even in the presence of cocultivated keratinocytes (Fig-
ure 3A). In contrast, junB2/2 fibroblasts contained a highblasts were included. Regardless of their genotype, the
fibroblasts remained vital for at least 10 days in the basal level of KGF and GM-CSF transcripts (3.5- and
34-fold, respectively), which were further increased inmatrix, and the increase in cell number of c-jun2/2 fibro-
blasts was only slightly reduced (, 20%) compared to the presence of keratinocytes (3.5- and 11-fold; Figure
3A). TNF-a was expressed at similar levels, irrespectivewild-type and junB2/2 cells (data not shown). These data
strongly suggest that c-Jun and JunB differently regu- of the genotype of the fibroblasts and independent of
the presence or absence of cocultivated keratinocyteslate the expression of fibroblast-derived soluble factors,
Jun-Dependent Mesenchymal–Epidermal Interaction
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Figure 1. Epidermis Formation in Organotypic Cultures Depends on the Genotype of Cocultured Fibroblasts
(A) Epidermal tissue morphology of human skin (top row) and in vitro cocultures of primary human keratinocytes and human dermal fibroblasts
(HDF) or immortalized mouse embryonic fibroblasts (MEF) with wild-type (wt), c-jun2/2, and junB2/2 genotype, respectively (indicated on the
left), in the collagen gel. Cross sections were either stained with Haematoxylin-Eosin (HE), or analyzed for the early and late differentiation
markers keratin 1/keratin 10 (green) and loricrin (red), respectively, by immunofluorescence. Nuclei were counterstained with bisbenzimide
(blue). The basement membrane (in sections from human skin) and keratinocytes-collagen matrix boundaries (organotypic cultures) are
indicated by a dotted line. Bar: 100 mm.
(B) Proliferation of basal keratinocytes in cocultures with human fibroblasts and mouse wild-type, c-jun2/2 and junB2/2 fibroblasts. The
percentage of proliferating basal cells was determined by immunofluorescence staining with a Ki67/Mib1 antibody and calculated as the
percentage of stained nuclei of total basal cell nuclei. Bars represent the average of three independent experiments counting nuclei in three
vision fields per experiment.
(data not shown). ELISA measuring the amount of KGF derived IL-1. Genotype-specific differences in fibro-
blast-derived KGF and GM-CSF seen upon cocultureand GM-CSF proteins in the culture medium (Figure 3B)
confirmed the RNA expression data. The level of KGF with keratinocytes (Figures 3A and 3B) were also ob-
served in fibroblast monocultures treated with IL-1awas greatly reduced in c-jun2/2 fibroblasts, but further
amplified in cells lacking JunB (Figure 3B). Very similar (data not shown).
These data show that c-Jun is required for the expres-results were observed for GM-CSF protein levels, which
were even more dramatically increased in junB2/2 fibro- sion of both KGF and GM-CSF, whereas JunB directly
or indirectly suppresses expression of both genes.blasts (Figure 3B).
ELISA using human and mouse specific IL-1 antibod-
ies confirmed that IL-1a in the culture medium is almost KGF and GM-CSF Regulate Specific Programs of
Keratinocyte Proliferation and Differentiationexclusively derived from keratinocytes. Similar levels of
human IL-1 were measured in all cocultures regardless The lack of KGF and GM-CSF expression in c-jun2/2
fibroblasts raised the possibility that the loss of eitherof the genotype of the fibroblasts (data not shown) ruling
out the possibility that alterations in KGF and GM-CSF one, or both, cytokines was responsible for the observed
phenotypes of keratinocyte growth and differentiationexpression are caused by differences in keratinocyte-
Cell
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Figure 2. Keratinocyte Proliferation Depends
on c-Jun and JunB Activity in Fibroblasts
(A) Western blot analysis of c-Jun and c-Jun-
ER protein expression in wild-type and c-jun2/2
fibroblasts. c-jun2/2/c-Jun-ER represents a
stable c-jun2/2 cell line, which expresses the
c-Jun-ER chimeric protein. As control for cor-
rect size of the fusion protein (72 kDa), F9
cells were transiently transfected with the
Ubi-c-Jun-ER expression vector (control).
The position of endogenous c-Jun (in wild-
type cells) and the inactive c-Jun-Neo fusion
protein (in c-jun2/2 cells), as well as a degra-
dation product of c-Jun-Neo (marked by an
asterisk) are indicated.
(B) Proliferative activity of basal keratinocytes
in cocultures with human fibroblasts and im-
mortalized mouse wild-type, c-jun2/2, c-jun2/2/
c-Jun-ER, junB2/2, and junB2/2/JunB-ER fi-
broblasts in the absence (2) or presence (1)
of 4OH-tamoxifen in the medium. The per-
centage of proliferating cells was determined
as described in Figure 1B.
(C) Epidermal tissue morphology of cross
sections of cocultures containing c-jun2/2/
c-Jun-ER (frozen sections) and junB2/2/JunB-
ER (paraffin sections) fibroblasts established
in the absence (2) or presence (1) of 4OH-
tamoxifen. Sections were either stained with
Haematoxylin-Eosin (HE), or analyzed for dif-
ferentiation markers as described in Figure
1A. Bar: 100 mm.
(Figure 1). To gain experimental support for this assump- lin granules and an enlarged, irregularly organized zone
of loricrin expressing cells. The stratum corneum wastion, we aimed to rescue the phenotype of the c-jun2/2
fibroblasts containing cultures by addition of recombi- much thicker when compared to cocultures containing
wild-type fibroblasts or c-jun2/2 cells in the presence ofnant KGF, GM-CSF, or both.
In epithelia of cocultures with c-jun2/2 fibroblasts, KGF (Figure 4A). When KGF and GM-CSF were added
simultaneously, the c-Jun-specific defects in prolifera-keratinocyte proliferation was completely restored by
supplementation with KGF (Figure 4B), resulting in a tion and differentiation were fully reverted, leading to
a hyperplastic and typically differentiated epithelium,multilayer epithelium composed of K1/K10-expressing
cells (Figure 4A). However, keratohyalin granules could which contained a small zone of well organized loricrin-
expressing cells (Figure 4A). Based on the histologicalnot be detected and expression of the late differentiation
marker loricrin was not restored (Figure 4A). Addition of and biochemical analysis (Figure 4), the cellular turnover
seemed to be accelerated, as indicated by the delayedGM-CSF similarly stimulated keratinocyte proliferation
(Figure 4B) but, different from KGF, caused the formation onset of K1/10. Other factors, such as EGF, TGFa, and
bFGF did not rescue the phenotype of the c-jun2/2 fibro-of a broad area of cell layers characterized by keratohya-
Jun-Dependent Mesenchymal–Epidermal Interaction
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Figure 3. c-Jun and JunB Regulate Expres-
sion of KGF and GM-CSF in Fibroblasts
(A) Relative mRNA levels of KGF and GM-CSF
in mouse wild-type (wt), c-jun2/2, and junB2/2
fibroblasts in the absence (2) or presence (1)
of cocultured keratinocytes was determined
by quantitative RT-PCR using b-tubulin for
normalization. RNA levels in wt cells grown
as monolayer were set as 1. Bars represent
the average of three independent experi-
ments.
(B) KGF and GM-CSF levels in the superna-
tants of cocultures containing wt, c-jun2/2,
and junB2/2 fibroblasts. Protein levels were
determined by ELISA in aliquots of two-day-
old conditioned media. The concentration of
KGF (26 6 3.4 pg/ml) and GM-CSF (10 6 2.5
pg/ml) in cocultures containing wt fibroblasts
was set as 1. Bars represent the average of
duplicate measurements performed in two in-
dependent experiments.
blasts containing cultures (data not shown). Obviously, to the formation of thin epithelia resembling the pheno-
type of the c-jun2/2 fibroblasts containing cultures (Fig-a coordinated action of both KGF and GM-CSF is essen-
tial to adjust the appropriate balance between cell prolif- ure 5), demonstrating that production of GM-CSF in fi-
broblasts is a rate-limiting step for development of theeration and differentiation required for the proper archi-
tecture of the epithelium. epithelium.
In the presence of neutralizing antibodies, which rec-
ognize human IL-1, keratinocyte proliferation and differ-Neutralizing IL-1 and GM-CSF Antibodies Affect
Epithelia in Organotypic Cocultures Containing entiation seen in cocultures containing junB2/2 fibro-
blasts can be normalized (Figure 5). Obviously, theWild-type and junB2/2 Fibroblasts
The phenotype of GM-CSF treated cocultures con- keratinocyte-independent high basal level expression
of KGF and GM-CSF in junB2/2 cells (Figure 3) is suffi-taining c-jun2/2 fibroblasts was very similar to the picture
obtained with fibroblasts lacking JunB (Figures 1A and cient to allow normal epithelium formation. In cultures
containing wild-type mouse fibroblasts, proliferation4A). Since basal and induced GM-CSF levels were
strongly elevated in junB2/2 fibroblasts (Figure 3), we and differentiation of keratinocytes were strongly re-
duced by IL-1 antibodies (Figure 5), resembling the phe-used neutralizing antibodies, specific for mouse GM-
CSF, to find out whether this increase is responsible, at notype seen with c-jun2/2 cells (Figure 1). Neither mouse
nor rabbit IgG, nor antibodies directed against humanleast in part, for the alterations in epithelium formation
in cocultures containing junB2/2. As shown in Figure bFGF and KGF, affected epithelium formation (data not
shown). These data provide functional evidence for the5, in the presence of antibodies, the hyperplastic and
disorganized structure of the epithelium was almost essential role of IL-1 to initiate cytokine-dependent mes-
enchymal–epidermal interaction.completely reversed to normal. The number of cell layers
was reduced, the structure became well organized, and
the strong overexpression of keratohyalin granules was Discussion
completely abolished. The almost complete rescue of
the phenotype was confirmed by the expression pattern Previous analyses have established specific require-
ments of the transcription factors c-Jun and JunB in cell-of K1/10 and loricrin (Figure 5). Using wild-type fibro-
blasts, addition of neutralizing GM-CSF antibodies led autonomous regulation of proliferation and cell cycle
Cell
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Figure 4. KGF and GM-CSF Induce Keratinocyte Proliferation and Differentiation in Organotypic Cultures Containing c-jun2/2 Fibroblasts
(A) Cultures containing c-jun2/2 fibroblasts were established in the absence or presence of KGF (10 ng/ml) and/or GM-CSF (100 ng/ml) and
compared to cultures containing wild-type (wt) fibroblasts. Cross sections were analyzed by hematoxylin-eosin (HE) staining, and immunofluo-
rescence analysis was performed as described in Figure 1. In the HE-stained section of c-jun2/2 cultures, the atrophic epithelium had detached
from the collagen gel during processing. Bar: 100 mm.
(B) Proliferative activity of basal keratinocytes in the cocultures shown in (A) were determined as described in Figure 1B. Bars represent the
average of three independent experiments counting Ki67-positive nuclei in three vision fields per experiment.
progression (Schreiber et al., 1999; Wisdom et al., 1999; The epithelialization process is controlled by the activ-
ity of cytokines and by cell–cell and cell–matrix inter-Bakiri et al., 2000; Passegue´ and Wagner, 2000).
Herein, we identify novel and specific transregulatory actions, such as integrins (Carroll et al., 1995). The ex-
perimental conditions used in our studies, in whichfunctions of c-Jun and JunB in the control of keratino-
cyte proliferation and differentiation as mediators of IL- fibroblasts were embedded in a collagen matrix, showed
that cell–cell contact between keratinocytes and fibro-1-regulated gene expression in fibroblasts. By using a
tissue-engineered, skin-equivalent model of human ke- blasts is not absolutely required, and allowed us to
specifically focus on the regulatory function of solubleratinocytes and immortalized c-Jun- or JunB-deficient
fibroblasts, fibroblast-derived KGF and GM-CSF could paracrine-acting factors. Several growth factors and in-
terleukins have been detected in normal and woundedbe identified as key regulators of the paracrine loop
responsible for the fine-tuned balance of keratinocyte skin, such as IL-1, IL-6, IL-8, GM-CSF, TGFa and TGFb,
NGF, and PDGF, as well as members of the FGF familyproliferation and differentiation to form an intact epider-
mis (Figure 6). This dynamic and reciprocal modulation (for review see Kupper and Groves 1995; Luger and
Schwarz, 1995; Schro¨der 1995). So far, their functionalof gene expression in keratinocytes and fibroblasts
(Smola et al., 1993; Maas-Szabowski et al., 2000) shares significance in the dermal–epidermal interplay is only
poorly understood. We concentrated our attention onmany aspects of the initial phase of re-epithelialization
and epidermis regeneration after wound healing (Werner factors that have already been suggested to play a role
both in vivo and in the in vitro organotypic coculture.et al., 1994). Therefore, we feel that our findings on Jun-
specific regulation of fibroblast-derived KGF and GM- In c-jun2/2 fibroblasts, KGF and GM-CSF expression is
hardly detectable. In contrast, in junB2/2 fibroblasts, ex-CSF will be of particular interest for these aspects of
skin biology. pression of both cytokines was enhanced and, as was
Jun-Dependent Mesenchymal–Epidermal Interaction
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Figure 5. Addition of Neutralizing IL-1 and
GM-CSF Antibodies Affect Epithelia in Or-
ganotypic Cocultures Containing Wild-type
and junB2/2 Fibroblasts
Cultures containing wt and junB2/2 fibroblasts
were generated in the absence or presence
of neutralizing antibodies recognizing either
murine GM-CSF (400 ng/ml) or human IL-1
(1mg/ml). Cross sections were analyzed by
hematoxylin-eosin (HE) staining, or analyzed
for differentiation markers as described in
Figure 1A. Bar: 100 mm.
concluded from the epidermal phenotype, the balance KGF to a proliferative epithelium lacking the expression
of marker genes for late differentiation, suggesting thatof KGF and GM-CSF was shifted toward an excess of
GM-CSF. This shift seems to be of functional signifi- proliferating cells need additional signals to efficiently
initiate the complete differentiation program.cance because GM-CSF neutralizing antibodies re-
duced the phenotype obtained by junB2/2 fibroblasts. In vivo, KGF is described as a paracrine-acting growth
factor produced by mesenchymal cells (such as fibro-Small differences in these rescued cultures (e.g., the
appearance of multiple layers of loricrin-expressing blasts) to stimulate epithelial cell proliferation via KGF
receptors expressed exclusively on epithelial cells (Ru-cells; Figure 5) may be explained by the aberrant expres-
sion of other cytokines or the incomplete neutralization bin et al., 1989; Miki et al., 1992; Werner et al., 1994).
Our findings that KGF has mitogenic activity but doesof GM-CSF by the antibodies. Moreover, addition of
recombinant GM-CSF in c-jun2/2 containing cocultures not induce differentiation are in line with previous data
showing that targeted KGF overexpression in keratino-lead to epithelia with enhanced proliferation and differ-
entiation similar to the junB2/2 phenotype. On the other cytes leads to epidermal hyperplasia (Guo et al., 1993).
Transgenic mice expressing a dominant-negative KGFhand, growth-inhibited thin epithelia in c-jun2/2 con-
taining cocultures could only be partially rescued by receptor in keratinocytes exhibit delayed wound healing
Cell
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a vast reservoir of IL-1, which is constitutively produced
by keratinocytes (Kupper and Groves, 1995). The release
of IL-1 is an early consequence of skin irritation and
injury, thus initiating a cascade of proinflammatory stim-
uli and initiating skin repair (Luger and Schwarz, 1995;
Dinarello 1996; Takei et al., 1998). In agreement with the
critical role of keratinocyte-derived IL-1 for KGF and
GM-CSF in keratinocyte-fibroblast cocultures, addition
of IL-1 strongly upregulated KGF and GM-CSF expres-
sion in fibroblast monocultures (data not shown).
Different lines of evidence have already suggested
a critical role of AP-1 subunits in cytokine-dependent
regulation of gene expression. First, IL-1 and TNFa
upregulate gene expression of jun, fos, and AP-1 target
genes such as matrix metalloproteinases and Il-2 (Bren-
ner et al., 1989; Muegge et al., 1989; Borden et al., 1996).
Second, IL-1 stimulates AP-1 and NFkB through activa-
Figure 6. Schematic Illustration of the Mesenchymal–Epithelial tion of the MAP kinases JNK and p38 and the IkB kinase
Cross-Talk in Skin Controlled by c-Jun and JunB in Fibroblasts
(IKK), respectively (Baud et al., 1999). c-Jun and ATF-2,
which are responsible for transcriptional activation of
c-jun expression in response to cytokines and genotoxic(Werner et al., 1992), whereas KGF-deficient mice did
agents, are efficiently phosphorylated by JNK and p38,not show abnormalities in epidermal growth and wound
respectively (Whitmarsh and Davis, 1996; Karin et al.,healing (Guo et al., 1996), suggesting functional com-
1997). Interestingly, AP-1 sites have been found in thepensation by other cytokines.
promoter region of the KGF and GM-CSF genes fromGM-CSF was first described in the hematopoietic sys-
mouse and human (Wang et al., 1994; Finch et al., 1995b;tem, where it promotes the proliferation of progenitors
Ye et al., 1996; N. Viebig, A. S., and P. A., unpublishedin the erythroid, eosinophil, and megakaryocyte lineage.
data), suggesting that Jun proteins directly regulate ex-On the other hand, GM-CSF supports the differentiation
pression by binding to the KGF and GM-CSF promoter.of hematopoietic progenitor cells to mature granulo-
In vitro binding studies confirmed direct binding of c-Juncytes and macrophages (Metcalf, 1998). In skin, GM-
and JunB to the AP-1 sites in the GM-CSF promoterCSF was described as stimulating keratinocyte pro-
(A. S. and P. A., unpublished data). The heterodimericliferation (Braunstein et al., 1994; N. M.-S. and N. F.,
partner of c-Jun involved in KGF and GM-CSF regulationunpublished data). We found that in organotypic cocul-
is presently unknown. Since keratinocyte growth andtures, addition of GM-CSF resulted in accelerated differ-
differentiation was not disturbed in cocultures con-entiation of keratinocytes, as shown by the strong in-
taining c-Fos-deficient fibroblasts (A. S., N. M.-S., N. F.,
crease in the number of cells containing keratohyalin
and P. A., unpublished data), it is unlikely that the regula-
granules and a thickened stratum corneum. Vice versa,
tory function of c-Jun is mediated through heterodimer-
addition of neutralizing GM-CSF antibodies greatly re-
ization with c-Fos.
duced keratinocyte proliferation and differentiation. In fibroblasts lacking JunB, basal level expression of
GM-CSF is an example of a physiologically relevant sol- both KGF and GM-CSF is enhanced and cocultivation
uble factor in skin that is able to modulate epidermal with keratinocytes or treatment with IL-1 superinduced
differentiation. Interestingly, neither GM-CSF (Huffman expression of both genes. JunB obviously acts as a
et al., 1996) nor GM-CSF b-receptor-deficient mice (Met- negative regulator of KGF and GM-CSF. The existence
calf et al., 1998) exhibit a skin phenotype, suggesting of AP-1 target genes that are antagonistically regulated
that GM-CSF is not absolutely required for skin develop- by c-Jun and JunB has been postulated (Chiu et al.,
ment and regeneration. However, the phenotypes ob- 1989; Schu¨tte et al., 1989; Bakiri et al., 2000). Using
tained in keratinocyte/fibroblast cocultures containing genetically defined loss-of-function mutant cells, we
elevated GM-CSF levels (e.g., using junB2/2 fibroblasts) have identified KGF and GM-CSF as endogenous target
share many characteristics of GM-CSF-treated skin genes, whose expression depends on the antagonistic
(Xing et al., 1997). Intradermal application of recombi- regulatory activity of c-Jun and JunB. The mechanism
nant GM-CSF in human skin leads to hyperproliferation of repression of KGF and GM-CSF by JunB is not clear,
and enlarged keratinocytes and enhanced levels of kera- but might be explained by the formation of transcription-
tohyalin granules in the stratum granulosum (Braunstein ally inactive c-Jun/JunB heterodimers (Deng and Karin,
et al., 1994). 1993). Alternatively, JunB may exhibit its repressor func-
Both proliferation and differentiation of keratinocytes tion through binding to a c-Jun-independent cis-acting
cocultured with wild-type mouse fibroblasts were found element, or indirectly through protein/protein interaction
to be strongly reduced in the presence of neutralizing with other transcription factors acting on the KGF and
IL-1 antibodies, demonstrating that release of IL-1 is a GM-CSF promoters.
rate-limiting, initiating step of the double paracrine loop Our data suggest a critical role of the ratio of cytokines
of mesenchymal–epidermal interaction. In line with with mitogenic potential (KGF), and those exhibiting
these findings, neutralizing IL-1 antibodies strongly re- both proliferation and differentiation inducing (GM-CSF)
duced expression of KGF in human fibroblasts (Maas- activity to allow normal epidermal tissue reconstitution.
In skin, homeostasis of the epidermis relies on a tightlySzabowski et al., 1999, 2000). In vivo, the epidermis is
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used. c-jun2/2 fibroblasts were cotransfected with 1.6 mg Ubiregulated balance between proliferation and differentia-
c-JunER plasmid together with 0.4 mg pSV-Hygro, a plasmid con-tion, where a continuous proliferation of keratinocytes
taining the hygromycin B resistance gene. After three weeks ofin the stratum basale is a prerequisite to replace the
cultivation in selection medium containing 50 mg/ml hygromycin B,
shedded material of the stratum corneum. During wound cell clones were isolated and expanded. The presence of c-Jun-ER
healing, this balance has to be temporally altered to sequences were monitored by PCR analysis of genomic DNA using
primers 59-ATGAGGAACCGCATTGCG-39 and 59-TGGAGATTCAAstimulate keratinocyte proliferation to achieve regenera-
GTCCCCAAAGCC-39. Expression of c-Jun-ER was confirmed bytion of the epidermis. Inappropriate adjustment will re-
Western blot using a mouse monoclonal anti-c-Jun antibody (Signalsult in the development of a hyperplastic skin pheno-
Transduction Laboratories). Generation of junB2/2 fibroblasts ex-type, as observed in KGF and GM-CSF transgenic mice
pressing JunB-ER will be described elsewhere (S. A., P. A., and
(Guo et al., 1993; Xing et al., 1997). An aberrant adjust- M. S.-K., unpublished data).
ment of the equilibrium between cytokines may also be
involved in pathological diseases in human, such as
Organotypic Cocultureslichen planus, psoriasis, or dermatofibrosis. Histologi-
Collagen gels (type I, rat tendon, 4 mg/ml) containing 2 3 105 humancally cutaneous lichen planus is characterized by epider-
or mouse fibroblasts per ml were cast in cell culture inserts (porous
mal hypergranulosis (a pronounced stratum granulosum size 3 mm; Falcon). NEK (1 3 106) were seeded onto the gels (Smola
with high amounts of keratohyalin granules), dermal fi- et al., 1998). After 24 hr, medium was replaced by DMEM with 50
brosis, and a dense infiltrate (Stefanidou et al., 1999). mg/ml L-ascorbic acid (Sigma) and cultures were raised to the air-
liquid interface. Medium containing the following additives was re-On the other hand, psoriatic epidermis exhibits hyper-
placed every two days: 10 ng/ml human KGF (BTS), 50 ng/ml mouseproliferation and absence of granular cells (Lever, 1984).
GM-CSF (Sigma), 100 ng/ml human GM-CSF, 400 ng/ml, and 1mg/There is evidence that the epidermal alterations in psori-
ml neutralizing antibodies against mouse GM-CSF and human IL-1,
asis and dermatofibroma are caused by changes in the respectively (R&D Systems). Tamoxifen (Sigma) was added twice a
underlying dermal fibroblasts. In vitro, normal keratino- day at a final concentration of 100 nM. Cultures were formalin fixed
cytes develop psoriatic-skin-like epidermal phenotypes or frozen for cryosectioning. Histology was visualized by Haematox-
ylin-Eosin (HE) staining.when growing on fibroblasts from psoriatic lesions
(Saiag et al., 1985). In dermatofibromas, a significant
hyperplasia of the epidermis can be observed overlying
Indirect Immunofluorescence Microscopy
the benign fibroblastic tumor nodule, indicating inter- Immunofluorescence was performed as described (Stark et al.,
play between fibroblasts and keratinocytes. This is ex- 1999). Proliferating cells were visualized using a mouse monoclonal
plained by fibrotic cells stimulating the epidermis in a anti-human Ki67/MibI antibody (Dianova). Differentiated keratino-
cytes were detected by mouse anti-human K1/K10 antibody (clonefashion similar to that of embryonic mesenchyme (Lever,
8.60, Sigma), or rabbit anti-human loricrin antiserum. Cell prolifera-1984).
tion was quantified by counting the ratio of labeled cells within theThe in vitro skin model described herein, using geneti-
basal layer of the epithelium in four to six vision fields of two to four
cally defined mutant fibroblasts, will be a powerful sys- sections derived from two to three independent experiments.
tem to study functional complementation of deficiencies
in order to identify critical cytokines, such as KGF and
Protein Determination by ELISAGM-CSF, and to define their specific activity to promote
Protein levels of KGF, GM-CSF, and IL-1a were determined by ELISAkeratinocyte proliferation, differentiation, or both. Our
(R&D Systems) in aliquots of 48 hr conditioned coculture medium ordata on the role of AP-1 in skin biology and the identifica-
of IL-1a stimulated (5 ng/ml; R&D Systems) fibroblast monocultures.
tion of AP-1 regulated cytokines may serve as the basis Protein values were measured as pg/ml and calculated as % of
for the dissection of disease mechanisms and will shed control.
new light on the molecular mechanism of dermal–
epidermal interactions in skin physiology and pathology.
Reverse Transcription and PCR
Total RNA was extracted and cDNA synthesis was performed as
Experimental Procedures described previously (Schorpp-Kistner et al., 1999). Quantitative
PCR was performed in a Lightcycler according to the manufacturer’s
Cell Culture instructions (Roche Diagnostics, Mannheim, Germany) using the
Normal human skin keratinocytes and dermal fibroblasts isolated following primers: KGF, 59-CTGGCCTTGTCACGACCTGTTTCT-39
from adult skin were cultivated as described (Stark et al., 1999). NEK and 59-CCCTTTCACTTTGCCTCGTTTGTC-39; (annealing at 568C);
were plated at 1.1 3 104 cells/cm2 on 24 hr precultured g-irradiated GM-CSF, 59-ATCAAAGAAGCCCTAAACCTCCTG-39; and 59-CTGGCC
fibroblast feeder cells (human, 70 Gy; mouse, 20 Gy). Mouse wild- TGGGCTTCCTCATT-39 (annealing at 578C). Primers for b-tubulin
type, c-jun2/2, and junB2/2 fibroblasts obtained from the outgrowth have been described (Schorpp-Kistner et al., 1999).
of mouse embryos were immortalized according to the 3T3 protocol
(Schreiber et al., 1999; S. A., P. A., and M. S.-K., unpublished data).
The viability of fibroblasts in the collagen matrix was determined Acknowledgments
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